Curanex Pharmaceuticals Inc (CURX)
Nasdaq: CURX · Pharmaceutical Preparations · Jericho, NY · filing with the SEC since 2024
Who runs Curanex Pharmaceuticals Inc
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Liu Jun
CEO and President. First filing Sep 2025, latest Sep 2, 2025, 0 filings in all.
Officers reporting now
5
of 8 people with a filing in the last fifteen months
Directors reporting now
3
8 people on the record since 2025
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Liu Jun | CEO and President | Sep 2025 | Sep 2, 2025 | none |
| Xie Liqin | Chief Operating Officer | Sep 2025 | Sep 2, 2025 | none |
| Zhang Ning | Chief Technology Officer | Sep 2025 | Sep 2, 2025 | none |
| Zhong Huijuan | Chief Science Officer | Sep 2025 | Sep 2, 2025 | none |
| Jing Dian Ying | Secretary | Sep 2025 | Sep 2, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hao Xiaohui | director | Sep 2025 | Sep 2, 2025 | none |
| Hsu Helen Hong | director | Sep 2025 | Sep 2, 2025 | none |
| Yan Yong | director | Sep 2025 | Sep 2, 2025 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Liu Chang | 10% owner | Sep 2025 | Sep 2, 2025 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.